233 related articles for article (PubMed ID: 18483308)
1. Requirement of hypoxia-inducible factor-1alpha down-regulation in mediating the antitumor activity of the anti-epidermal growth factor receptor monoclonal antibody cetuximab.
Li X; Lu Y; Liang K; Pan T; Mendelsohn J; Fan Z
Mol Cancer Ther; 2008 May; 7(5):1207-17. PubMed ID: 18483308
[TBL] [Abstract][Full Text] [Related]
2. 1, 9-Pyrazoloanthrones downregulate HIF-1α and sensitize cancer cells to cetuximab-mediated anti-EGFR therapy.
Lu Y; Li X; Lu H; Fan Z
PLoS One; 2010 Dec; 5(12):e15823. PubMed ID: 21209911
[TBL] [Abstract][Full Text] [Related]
3. Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1alpha.
Lu Y; Liang K; Li X; Fan Z
Mol Cancer; 2007 Oct; 6():63. PubMed ID: 17931419
[TBL] [Abstract][Full Text] [Related]
4. The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression.
Luwor RB; Lu Y; Li X; Mendelsohn J; Fan Z
Oncogene; 2005 Jun; 24(27):4433-41. PubMed ID: 15806152
[TBL] [Abstract][Full Text] [Related]
5. The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex.
Li X; Fan Z
Cancer Res; 2010 Jul; 70(14):5942-52. PubMed ID: 20634405
[TBL] [Abstract][Full Text] [Related]
6. The anti-EGFR antibody cetuximab sensitizes human head and neck squamous cell carcinoma cells to radiation in part through inhibiting radiation-induced upregulation of HIF-1α.
Lu H; Liang K; Lu Y; Fan Z
Cancer Lett; 2012 Sep; 322(1):78-85. PubMed ID: 22348829
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression.
Peng XH; Karna P; Cao Z; Jiang BH; Zhou M; Yang L
J Biol Chem; 2006 Sep; 281(36):25903-14. PubMed ID: 16847054
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells.
Sun YZ; Cai N; Liu NN
Cell Physiol Biochem; 2017; 44(4):1640-1650. PubMed ID: 29216640
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis.
Tanaka H; Yamamoto M; Hashimoto N; Miyakoshi M; Tamakawa S; Yoshie M; Tokusashi Y; Yokoyama K; Yaginuma Y; Ogawa K
Cancer Res; 2006 Dec; 66(23):11263-70. PubMed ID: 17145871
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
11. Functional cooperation between HIF-1α and c-Jun in mediating primary and acquired resistance to gefitinib in NSCLC cells with activating mutation of EGFR.
Meng S; Wang G; Lu Y; Fan Z
Lung Cancer; 2018 Jul; 121():82-90. PubMed ID: 29858032
[TBL] [Abstract][Full Text] [Related]
12. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
[TBL] [Abstract][Full Text] [Related]
13. Cetuximab reverses the Warburg effect by inhibiting HIF-1-regulated LDH-A.
Lu H; Li X; Luo Z; Liu J; Fan Z
Mol Cancer Ther; 2013 Oct; 12(10):2187-99. PubMed ID: 23920275
[TBL] [Abstract][Full Text] [Related]
14. Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor-targeted therapy with cetuximab and gefitinib.
Luwor RB; Lu Y; Li X; Liang K; Fan Z
Cancer Lett; 2011 Jul; 306(1):85-91. PubMed ID: 21411223
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of HIF-1α inhibits the proliferation, migration, and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression.
Zhang J; Xu J; Dong Y; Huang B
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29899167
[TBL] [Abstract][Full Text] [Related]
16. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
17. Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1α pathway.
Yoshikawa Y; Takano O; Kato I; Takahashi Y; Shima F; Kataoka T
Cancer Lett; 2017 Dec; 410():82-91. PubMed ID: 28951129
[TBL] [Abstract][Full Text] [Related]
18. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.
Mabjeesh NJ; Willard MT; Frederickson CE; Zhong H; Simons JW
Clin Cancer Res; 2003 Jul; 9(7):2416-25. PubMed ID: 12855613
[TBL] [Abstract][Full Text] [Related]
19. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
[TBL] [Abstract][Full Text] [Related]
20. Oltipraz and dithiolethione congeners inhibit hypoxia-inducible factor-1alpha activity through p70 ribosomal S6 kinase-1 inhibition and H2O2-scavenging effect.
Lee WH; Kim YW; Choi JH; Brooks SC; Lee MO; Kim SG
Mol Cancer Ther; 2009 Oct; 8(10):2791-802. PubMed ID: 19789218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
